SlideShare a Scribd company logo
1 of 1
Martin Stengelin, Ph.D.
Martin Stengelin is a Senior Scientific Manager at Meso Scale Diagnostics, LLC (MSD®). He has 17 years of
immunoassay development experience. Dr. Stengelin began his career at Dade Behring (now Siemens), and has
beenat MSD since2003.He earned his Ph.D. at the Max Planck Institute for Biophysics in Frankfurt and his MBAat
the University of Delaware. Dr. Stengelin is currently the Principal Investigator of a 5-year NIH grant to develop
samplesparing assays for monitoring immune responses. He also manages assaydevelopment projects related to
infectious diseases, immunology, and cancer.

More Related Content

More from Lawrence Hwang

U-PLEX_Custom_Biomarker_Assays_Human_Insert_Final
U-PLEX_Custom_Biomarker_Assays_Human_Insert_FinalU-PLEX_Custom_Biomarker_Assays_Human_Insert_Final
U-PLEX_Custom_Biomarker_Assays_Human_Insert_FinalLawrence Hwang
 
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARS
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARSUmek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARS
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARSLawrence Hwang
 
MSD Poster Tau CTAD_MARS_REVIEW
MSD Poster Tau CTAD_MARS_REVIEWMSD Poster Tau CTAD_MARS_REVIEW
MSD Poster Tau CTAD_MARS_REVIEWLawrence Hwang
 
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_finalLawrence Hwang
 
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_FinalLawrence Hwang
 
ECI_Lu_U-PLEX Development
ECI_Lu_U-PLEX DevelopmentECI_Lu_U-PLEX Development
ECI_Lu_U-PLEX DevelopmentLawrence Hwang
 
FINAL_Tau S-PLEX Assay abstract_Mathew
FINAL_Tau S-PLEX Assay abstract_MathewFINAL_Tau S-PLEX Assay abstract_Mathew
FINAL_Tau S-PLEX Assay abstract_MathewLawrence Hwang
 
AAPS 2015_W3081_Biomarker Screening Poster_Russell
AAPS 2015_W3081_Biomarker Screening Poster_RussellAAPS 2015_W3081_Biomarker Screening Poster_Russell
AAPS 2015_W3081_Biomarker Screening Poster_RussellLawrence Hwang
 
AAPS 2015_M1028_U-PLEX Feasibility Poster_Russell
AAPS 2015_M1028_U-PLEX Feasibility Poster_RussellAAPS 2015_M1028_U-PLEX Feasibility Poster_Russell
AAPS 2015_M1028_U-PLEX Feasibility Poster_RussellLawrence Hwang
 

More from Lawrence Hwang (10)

U-PLEX_Custom_Biomarker_Assays_Human_Insert_Final
U-PLEX_Custom_Biomarker_Assays_Human_Insert_FinalU-PLEX_Custom_Biomarker_Assays_Human_Insert_Final
U-PLEX_Custom_Biomarker_Assays_Human_Insert_Final
 
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARS
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARSUmek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARS
Umek - Lay Interim Report v2- 9977_Expedited_11.12.17_LH_Edits_FINAL_FOR_MARS
 
MSD Poster Tau CTAD_MARS_REVIEW
MSD Poster Tau CTAD_MARS_REVIEWMSD Poster Tau CTAD_MARS_REVIEW
MSD Poster Tau CTAD_MARS_REVIEW
 
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final
6-8-2015 AACC Poster HIV p24 S-PLEX - Stengelin_final
 
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
6-23-2015 AACC Poster HIV Incidence Assay - Stengelin_Final
 
ECI_Lu_U-PLEX Development
ECI_Lu_U-PLEX DevelopmentECI_Lu_U-PLEX Development
ECI_Lu_U-PLEX Development
 
FINAL_Tau S-PLEX Assay abstract_Mathew
FINAL_Tau S-PLEX Assay abstract_MathewFINAL_Tau S-PLEX Assay abstract_Mathew
FINAL_Tau S-PLEX Assay abstract_Mathew
 
Poster NBC-15-487_Lu
Poster NBC-15-487_LuPoster NBC-15-487_Lu
Poster NBC-15-487_Lu
 
AAPS 2015_W3081_Biomarker Screening Poster_Russell
AAPS 2015_W3081_Biomarker Screening Poster_RussellAAPS 2015_W3081_Biomarker Screening Poster_Russell
AAPS 2015_W3081_Biomarker Screening Poster_Russell
 
AAPS 2015_M1028_U-PLEX Feasibility Poster_Russell
AAPS 2015_M1028_U-PLEX Feasibility Poster_RussellAAPS 2015_M1028_U-PLEX Feasibility Poster_Russell
AAPS 2015_M1028_U-PLEX Feasibility Poster_Russell
 

Martin Stengelin Bio_FINAL

  • 1. Martin Stengelin, Ph.D. Martin Stengelin is a Senior Scientific Manager at Meso Scale Diagnostics, LLC (MSD®). He has 17 years of immunoassay development experience. Dr. Stengelin began his career at Dade Behring (now Siemens), and has beenat MSD since2003.He earned his Ph.D. at the Max Planck Institute for Biophysics in Frankfurt and his MBAat the University of Delaware. Dr. Stengelin is currently the Principal Investigator of a 5-year NIH grant to develop samplesparing assays for monitoring immune responses. He also manages assaydevelopment projects related to infectious diseases, immunology, and cancer.